Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: Secondary analysis of the reduction by dutasteride of prostate cancer events (REDUCE) trial

Claus Roehrborn, J. Curtis Nickel, Gerald L. Andriole, R. Paul Gagnier, Libby Black, Timothy H. Wilson, Roger S. Rittmaster

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: Secondary analysis of the reduction by dutasteride of prostate cancer events (REDUCE) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences